Trial · NCT01462630
Adverse events78
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 78
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Rhinitis | Infections and infestations | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Low hemoglobin | Blood and lymphatic system disorders | Treatment (Enzyme Inhibitor Therapy) | 9 | 29 | |
| other | Low absolute neutrophil count | Blood and lymphatic system disorders | Treatment (Enzyme Inhibitor Therapy) | 3 | 29 | |
| other | Low white blood cell count | Investigations | Treatment (Enzyme Inhibitor Therapy) | 7 | 29 | |
| other | Lymphocyte count decrease | Investigations | Treatment (Enzyme Inhibitor Therapy) | 4 | 29 | |
| other | Edema | General disorders | Treatment (Enzyme Inhibitor Therapy) | 3 | 29 | |
| other | Hypertension | Vascular disorders | Treatment (Enzyme Inhibitor Therapy) | 14 | 29 | |
| other | Ortho-hypotension | Vascular disorders | Treatment (Enzyme Inhibitor Therapy) | 2 | 29 | |
| other | Palpitation | Cardiac disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Dizzeness | Nervous system disorders | Treatment (Enzyme Inhibitor Therapy) | 8 | 29 | |
| other | Fatigue | General disorders | Treatment (Enzyme Inhibitor Therapy) | 18 | 29 | |
| other | Anxiety | Psychiatric disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Chills | General disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Hair color changes | Skin and subcutaneous tissue disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Rash | Skin and subcutaneous tissue disorders | Treatment (Enzyme Inhibitor Therapy) | 3 | 29 | |
| other | Pruritis | Skin and subcutaneous tissue disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Palmer-Planter erythrodysesthia syndrome | Immune system disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Hemorrhage | General disorders | Treatment (Enzyme Inhibitor Therapy) | 1 | 29 | |
| other | Nausea | Gastrointestinal disorders | Treatment (Enzyme Inhibitor Therapy) | 14 | 29 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01462630/events